X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aged (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
cancer (3) 3
chemotherapy (3) 3
hematology, oncology and palliative medicine (3) 3
humans (3) 3
index medicus (3) 3
male (3) 3
metastasis (3) 3
middle aged (3) 3
oncology (3) 3
androgen antagonists - therapeutic use (2) 2
disease-free survival (2) 2
follow-up studies (2) 2
iii trial (2) 2
life sciences (2) 2
mitoxantrone (2) 2
neoplasm staging (2) 2
prostate cancer (2) 2
prostatic neoplasms - drug therapy (2) 2
prostatic neoplasms - mortality (2) 2
radiotherapy (2) 2
survival (2) 2
taxoids - administration & dosage (2) 2
1st cycle (1) 1
[ sdv ] life sciences [q-bio] (1) 1
[sdv.can]life sciences [q-bio]/cancer (1) 1
adjuvant (1) 1
adolescent (1) 1
adult (1) 1
agriculture (1) 1
alpha-fetoproteins - metabolism (1) 1
analysis (1) 1
androgen antagonists - administration & dosage (1) 1
androgens (1) 1
antigen progression (1) 1
antigens (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
biomarkers (1) 1
biomarkers, tumor - blood (1) 1
biometry (1) 1
bleomycin - administration & dosage (1) 1
cancer therapies (1) 1
chorionic gonadotropin - blood (1) 1
cisplatin (1) 1
cisplatin - administration & dosage (1) 1
complete-response (1) 1
consensus conference (1) 1
dense chemotherapy (1) 1
dose-response relationship, drug (1) 1
drug administration schedule (1) 1
estramustine (1) 1
estramustine - administration & dosage (1) 1
etoposide (1) 1
etoposide - administration & dosage (1) 1
female (1) 1
france (1) 1
granulocyte colony-stimulating factor - administration & dosage (1) 1
guidelines (1) 1
high-dose chemotherapy (1) 1
human immunodeficiency virus--hiv (1) 1
ifosfamide - administration & dosage (1) 1
infections (1) 1
international agencies (1) 1
irradiation (1) 1
kaplan-meier estimate (1) 1
lenograstim (1) 1
maximum tolerated dose (1) 1
mediastinal neoplasms - blood (1) 1
mediastinal neoplasms - drug therapy (1) 1
mediastinal neoplasms - mortality (1) 1
mediastinal neoplasms - pathology (1) 1
medical prognosis (1) 1
men (1) 1
neoplasm invasiveness - pathology (1) 1
neoplasm metastasis (1) 1
neoplasm recurrence, local - epidemiology (1) 1
neoplasm recurrence, local - pathology (1) 1
neoplasms, germ cell and embryonal - blood (1) 1
neoplasms, germ cell and embryonal - drug therapy (1) 1
neoplasms, germ cell and embryonal - mortality (1) 1
neoplasms, germ cell and embryonal - pathology (1) 1
orchiectomy (1) 1
organoplatinum compounds - administration & dosage (1) 1
oxaliplatin (1) 1
paclitaxel - administration & dosage (1) 1
peritoneal neoplasms - blood (1) 1
peritoneal neoplasms - drug therapy (1) 1
peritoneal neoplasms - mortality (1) 1
peritoneal neoplasms - pathology (1) 1
precision medicine (1) 1
prednisone (1) 1
product development (1) 1
prognosis (1) 1
proportional hazards models (1) 1
prostate-specific antigen - blood (1) 1
prostatic neoplasms - pathology (1) 1
quality-of-life (1) 1
radiation therapy (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 2, pp. 149 - 158
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 13, pp. 1442 - 1450
Summary Background Poor prognosis germ-cell tumours are only cured in about half of patients. We aimed to assess whether treatment intensification based on an... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | 1ST CYCLE | ETOPOSIDE | THERAPY | SOUTHWEST-ONCOLOGY-GROUP | CISPLATIN | ONCOLOGY | DENSE CHEMOTHERAPY | HIGH-DOSE CHEMOTHERAPY | COMPLETE-RESPONSE | CANCER | Testicular Neoplasms - mortality | Prognosis | Follow-Up Studies | Peritoneal Neoplasms - blood | Humans | Middle Aged | Male | Mediastinal Neoplasms - mortality | Neoplasms, Germ Cell and Embryonal - blood | Testicular Neoplasms - pathology | Cisplatin - administration & dosage | Young Adult | Mediastinal Neoplasms - drug therapy | Neoplasm Metastasis | Organoplatinum Compounds - administration & dosage | Peritoneal Neoplasms - drug therapy | Oxaliplatin | Chorionic Gonadotropin - blood | Adult | Female | Neoplasms, Germ Cell and Embryonal - drug therapy | Paclitaxel - administration & dosage | Precision Medicine | alpha-Fetoproteins - metabolism | Peritoneal Neoplasms - pathology | Lenograstim | Mediastinal Neoplasms - blood | Neoplasms, Germ Cell and Embryonal - mortality | Etoposide - administration & dosage | Survival Rate | Bleomycin - administration & dosage | Peritoneal Neoplasms - mortality | Recombinant Proteins - administration & dosage | Biomarkers, Tumor - blood | Ifosfamide - administration & dosage | International Agencies | Testicular Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mediastinal Neoplasms - pathology | Adolescent | Aged | Neoplasm Staging | Testicular Neoplasms - blood | Neoplasms, Germ Cell and Embryonal - pathology | Granulocyte Colony-Stimulating Factor - administration & dosage | Chemotherapy | Tumors | Cancer | Analysis
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 7, pp. 787 - 794
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.